2021年２月３日「医療の現場で培われてきた匠の技を未来につなぐ」 A I医療機器の開発を担うアイリス株式会社から沖山翔氏が登壇

Sho Okiyama is the CEO and founder of Aillis Inc., a Tokyo-based startup developing an AI device for early and accurate detection of influenza. Although the flu is a common infectious disease, it changes rapidly and there are still many challenges in diagnosis. The device Aillis is developing takes a completely new approach using machine-learning techniques to identify influenza follicles — blister-like swellings that are early indicators of the disease —from throat images.
Sho is also a doctor specializing in emergency medicine who has worked as an emergency physician at the Japanese Red Cross Medical Center, as a flight doctor traveling where needed on a remote island and as a ship's doctor. Prior to founding Aillis, he was the executive officer of the Japanese health care company Medley Inc. He earned his medical degree from the University of Tokyo in 2010.

Ross Rowbury has been observing and living and working in Japan for four decades. Originally commencing his career in finance in Tokyo in the early 1980’s he later moved into public relations and communications holding senior positions at Gavin Anderson & Co (now Kreab,) and PRAP Japan. Most recently he headed the Edelman business in Japan for 10 years until July 2020. Ross is studying to become a traditional storyteller (kataribe) of Japanese legends while doing freelance consulting for a number of firms on their Japan business strategy. He is also Visiting Professor of Asian Marketing at Doshisha University in Kyoto.